Altogether, our data reveal a significant and previously unknown interaction between EGCs and TAMs in the CRC TME, with EGC-derived IL-6 acting as a crucial regulator in driving SPP1+ TAM differentiation. The gene discussed is IL6; the disease is colorectal carcinoma.